Gaviscon forte suspension 150ml peppermint fl

Description

Composition
Active substance:
Sodium alginate 1000 mg, potassium carbonate 200 mg
Excipients:
Calcium carbonate 200 mg, carbomer 40 mg, 40 mg methyl parahydroxybenzoate, propyl parahydroxybenzoate 6 mg Sodium hydroxide 14.44 mg sodium saccharinate 10 mg, 6 mg peppermint flavor, purified water to 10 ml;
Description:
Viscous slurry, from almost white to light brown in color, with a minty smell.
Product form:
Oral suspension [mint]
150 ml amber glass vials with a polypropylene cap, providing a first control opening. Instructions for use under the label.
Contraindications
Hypersensitivity to the drug, children’s age (12 years).
Indications
Symptomatic treatment of dyspepsia associated with gastric hyperacidity and gastroesophageal reflux (heartburn, acid regurgitation), a feeling of heaviness in the stomach after ingestion, including during pregnancy.
Interaction with other drugs
Since the calcium carbonate, part of the drug exhibits antacid activity between drug intake Geviskon® forte and other drugs must be at least 2 hours, particularly while receiving H2-blockers of histamine receptors, antibiotics from the group of tetracycline, digoxin, fluoroquinolone iron salts, ketoconazole, neuroleptics, thyroid hormone, levothyroxine sodium, penicillamine, beta-blockers (atenolol, metoprolol, propranolol), corticosteroids, chloroquine, bisphosphonate E and estramustine.
Overdose
Symptoms may experience bloating.
Treatment: symptomatic.
pharmachologic effect
Pharmacological group:
Reflux esophagitis treatment for
Pharmacodynamics:
When ingestion of the active ingredients of the drug Geviskon® fort quickly react with acidic stomach contents. Thus formed alginate gel with a pH close to neutral. The gel forms a protective barrier on the surface of the gastric contents, preventing the occurrence of gastroesophageal reflux (Scored reverse stomach contents into the esophagus) for up to four hours. In severe cases of reflux (regurgitation), the gel enters the esophagus, the stomach contents ahead of the rest, where it reduces irritation of esophageal mucosa.
Reducing irritation felt after 3-4 minutes after administration.
Pharmacokinetics:
The mechanism of action of the drug Geviskon® forte is physical and does not depend on absorption into the systemic circulation.
Pregnancy and breast-feeding
Geviskon® Forte can be used during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
estimates of frequency of adverse reactions produced on the basis of the following criteria: very common (> 1/10), common (> 1/100, 1/1000, 1/10000,
Disorders of immune system: unknown frequency – anaphylactic and anaphylactoid reactions, hypersensitivity reactions (urticaria).
Violations of the respiratory system, thorax and mediastinum: unknown frequency – respiratory effects (bronchospasm).
If any of these instructions side effects are compounded, or if you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
In 10 ml of a suspension of sodium content of 106 mg (4.6 mmol) and potassium 78 mg (2.0 mmol). This should be considered as necessary dieting with a very limited content of salts, for example, in some cases of congestive heart failure and renal impairment or when taking drugs which can increase the level of potassium in the plasma.
In 10 ml suspension content of calcium carbonate is 200 mg (2.0 mmol). The drug should be taken with caution in patients with hypercalcemia, and recurrent neyrokaltsinozom formation of kidney stones containing calcium.
If there is no improvement in symptoms within 7 days should consult a physician.
Effects on ability to transp. Wed. and fur .:
The drug has no effect on the ability to drive vehicles and mechanisms, as well as other classes of potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
Store at a temperature of 15 – 30 ° C. Keep out of the reach of children.
Dosing and Administration
Adults and children over 12 years: inside, 5-10 ml after meals and at bedtime.
The maximum daily dose of 40 ml.
If after 7 days of dosing symptoms persist, consult your doctor to review treatment.
Please read the instructions before taking the drug.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist